The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Endotoxemia, nutrition, and cardiometabolic disorders
Abstract
Aims Circulating lipopolysaccharides (LPSs), associated with both infection and inflammation, may arise from the gastrointestinal tract microbiota, and the levels may be affected by daily nutrition. We investigated whether nutrient intake affects the association of serum LPS activity with prevalent obesity, metabolic syndrome (MetS), diabetes, and coronary heart disease (CHD) and with the risk of incident CHD events.Methods The nutrition cohort (n = 2,452, mean age ± SD, 52.2 ± 10.1 years) of the FINRISK 1997 Study was followed up for 10 years. Information on macronutrient intake at baseline was collected from 24-h dietary recall. Serum endotoxin activities were determined by the Limulus amebocyte lysate assay.Results LPS activity was associated directly with the total energy intake and indirectly with carbohydrate intake in lean, healthy subjects. High LPS was significantly associated with prevalent obesity, MetS, diabetes, and CHD events, independently of established risk factors, CRP, and total energy or nutrient intake. The ORs (95 % CI) were 1.49 (1.21-1.85, p < 0.001, Q2-4 vs. Q1) for obesity, 2.56 (1.97-3.32, p < 0.001, Q2-4 vs. Q1) for MetS, 1.94 (1.06-3.52, p = 0.031, Q2-4 vs. Q1) for CHD, and 1.01 (1.00-1.01, p = 0.032, LPS unit) for diabetes. In the follow-up, high LPS was significantly associated with the risk of CHD events with a hazard ratio of 1.88 (1.13-3.12, p = 0.013, Q2-4 vs. Q1). This association was independent of baseline established risk factors, diet, obesity, MetS, and diabetes.Conclusion A high serum LPS activity is strongly associated with cardiometabolic disorders, which supports the role of bacterial infections and immune response in their etiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Commensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
WHO MONICA Project Principal Invest (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90084-4 · Cited by 1,846
Human blood pressure determination by sphygmomanometry.
Perloff, D., Grim, C. M., Flack, J. M., Frohlich, E. D., Hill, M. D., McDonald, M., & Morgenstern, B. Z. (1993) · Circulation · doi:10.1161/01.cir.88.5.2460 · Cited by 1,592
Kornitzer, M., Berghmans, L., Wilmet, M. D., Darquennes, H., Lagasse, R., & Payen, R. (1988) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 1,270
Dental disease and risk of coronary heart disease and mortality.
Destefano, F. R., Anda, R. F., Kahn, H. S., Williamson, D. F., & Russell, C. M. (1993) · BMJ · doi:10.1136/bmj.306.6879.688 · Cited by 1,113
Erridge, C., Attina, T., Spickett, C. M., & Webb, D. J. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1286 · Cited by 776
Chylomicrons promote intestinal absorption of lipopolysaccharides
Ghoshal, S., Witta, J., Zhong, J., de Villiers, W., & Eckhardt, E. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800156-jlr200 · Cited by 662
Flagged first, then by citations
Cited by
Sorted by citations
The gut microbiota at the intersection of diet and human health
Gentile, C. L., & Weir, T. L. (2018) · Science · doi:10.1126/science.aau5812 · Cited by 1,049
Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors
Fiuza-Luces, C., Santos-Lozano, A., Joyner, M., Carrera-Bastos, P., Picazo, O., Zugaza, J. L., Izquierdo, M., Ruilope, L. M., & Lucia, A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0065-1 · Cited by 803
Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development
Ghosh, S. S., Wang, J., Yannie, P. J., & Ghosh, S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz039 · Cited by 838
Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
Mohammad, S., & Thiemermann, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594150 · Cited by 585
Therapies from Fucoidan: An Update
Fitton, J., Stringer, D., & Karpiniec, S. (2015) · Marine Drugs · doi:10.3390/md13095920 · Cited by 418
Metabolic endotoxemia with obesity: Is it real and is it relevant?
Boutagy, N. E., McMillan, R. P., Frisard, M. I., & Hulver, M. W. (2016) · Biochimie · doi:10.1016/j.biochi.2015.06.020 · Cited by 413
Missing Teeth Predict Incident Cardiovascular Events, Diabetes, and Death
Liljestrand, J. M., Havulinna, A. S., Paju, S., Männistö, S., Salomaa, V. V., & Pussinen, P. J. (2015) · Journal of Dental Research · doi:10.1177/0022034515586352 · Cited by 234
Self-citationGut Microbiome and Obesity: A Plausible Explanation for Obesity
Sanmiguel, C. P., Gupta, A., & Mayer, E. A. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0152-0 · Cited by 210
Guerville, M., & Boudry, G. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00098.2016 · Cited by 195
The gut microbiota and its interactions with cardiovascular disease
Xu, H., Wang, X., Feng, W., Liu, Q., Zhou, S., Liu, Q., & Cai, L. (2020) · Microbial Biotechnology · doi:10.1111/1751-7915.13524 · Cited by 196
Stenman, L. K., Lehtinen, M. J., Meland, N., Christensen, J. E., Yeung, N., Saarinen, M. T., Courtney, M., Burcelin, R., Lähdeaho, M.-L., Linros, J., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.036 · Cited by 177
The oral microbiome in the pathophysiology of cardiovascular disease
Tonelli, A., Lumngwena, E. N., & Ntusi, N. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00825-3 · Cited by 184
Butyrate-producing bacteria and the gut-heart axis in atherosclerosis
Chen, W., Zhang, S., Wu, J., Ye, T., Wang, S., Wang, P., & Xing, D. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.037 · Cited by 150
Periodontitis and cardiometabolic disorders: The role of lipopolysaccharide and endotoxemia
Pussinen, P. J., Kopra, E., Pietiäinen, M., Lehto, M. J., Zarić, S., Paju, S., & Salminen, A. (2022) · Periodontology 2000 · doi:10.1111/prd.12433 · Cited by 142
Self-citationRole of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder
Luqman, A., Hassan, A., Ullah, M., Naseem, S., Ullah, M., Zhang, L., Din, A. U., Ullah, K., Ahmad, W., & Wang, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1321395 · Cited by 145
MINAMI, J., Iwabuchi, N., Tanaka, M., Yamauchi, K., Xiao, J., Abe, F., & Sakane, N. (2018) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.18-001 · Cited by 123
Martínez-Colón, G. J., Ratnasiri, K., Chen, R., Jiang, S., ZANLEY, E. J., Rustagi, A., Verma, R., Chen, H. M., Andrews, J. R., Mertz, K. D., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm9151 · Cited by 140
Moludi, J., Maleki, V., Vayghan, H. J., Vaghef‐Mehrabany, E., & Alizadeh, M. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13250 · Cited by 115
Ghosh, S. S., He, H., Wang, J., Gehr, T. W. B., & Ghosh, S. (2018) · Tissue Barriers · doi:10.1080/21688370.2018.1425085 · Cited by 110
Mediators between oral dysbiosis and cardiovascular diseases
Pietiäinen, M., Liljestrand, J. M., Kopra, E., & Pussinen, P. J. (2018) · European Journal Of Oral Sciences · doi:10.1111/eos.12423 · Cited by 113
Self-citationNutritional modulation of gut microbiota — the impact on metabolic disease pathophysiology
Ojeda, P., Bobe, A. M., Dolan, K. T., Leone, V., & Martinez, K. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.013 · Cited by 108
Association of Endodontic Lesions with Coronary Artery Disease
Liljestrand, J. M., Mäntylä, P., Paju, S., Buhlin, K., Kopra, K. A. E., Persson, G. R., Hernández, M., Nieminen, M. S., Sinisalo, J. P., Tjäderhane, L., et al. (2016) · Journal of Dental Research · doi:10.1177/0022034516660509 · Cited by 99
Self-citationKarhu, E., Forsgård, R. A., Alanko, L., Alfthan, H. V., Pussinen, P. J., Hämäläinen, E. K., & Korpela, R. (2017) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3739-1 · Cited by 99
Self-citationAndré, P., Laugerette, F., & Féart, C. (2019) · Nutrients · doi:10.3390/nu11081887 · Cited by 89
Mokkala, K., Pellonperä, O., Röytiö, H., Pussinen, P. J., Rönnemaa, T., & Laitinen, K. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.015 · Cited by 86
Self-citationDietary patterns reflecting healthy food choices are associated with lower serum LPS activity
Ahola, A. J., Lassenius, M. I., Forsblom, C. M., Harjutsalo, V., Lehto, M. J., & Groop, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-06885-7 · Cited by 86
Self-citationAlbany, C. J., Trevelin, S. C., Giganti, G., Lombardi, G., & Scottà, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02795 · Cited by 87
The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy
Forkosh, E., & Ilan, Y. (2019) · Open Heart · doi:10.1136/openhrt-2018-000993 · Cited by 86
Roles of Oral Infections in the Pathomechanism of Atherosclerosis
Aarabi, G., Heydecke, G., & Seedorf, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071978 · Cited by 80
Hu, N., & Zhang, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.01.010 · Cited by 77
Hodges, J. K., Sasaki, G. Y., & Bruno, R. S. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108478 · Cited by 80
Guerville, M., Leroy, A., Sinquin, A., Laugerette, F., Michalski, M., & Boudry, G. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00372.2016 · Cited by 81
Tremellen, K. P. (2016) · Basic and Clinical Andrology · doi:10.1186/s12610-016-0034-7 · Cited by 78
Lipopolysaccharide, a possible molecular mediator between periodontitis and coronary artery disease
Liljestrand, J. M., Paju, S., Buhlin, K., Persson, G. R., Sarna, S. J., Nieminen, M. S., Sinisalo, J. P., Mäntylä, P., & Pussinen, P. J. (2017) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12751 · Cited by 71
Self-citationPei, R., DiMarco, D. M., Putt, K. K., Martin, D., Gu, Q., Chitchumroonchokchai, C., White, H. M., Scarlett, C. O., Bruno, R. S., & Bolling, B. W. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517003038 · Cited by 71
Alfakry, H., Malle, E., Koyani, C. N., Pussinen, P. J., & Sorsa, T. A. (2015) · Innate Immunity · doi:10.1177/1753425915617521 · Cited by 71
Self-citationGut Microbiota Parameters Potentially Useful in Clinical Perspective
Pierro, F. D. (2021) · Microorganisms · doi:10.3390/microorganisms9112402 · Cited by 67
Vliex, L. M. M., Penders, J., Nauta, A., Zoetendal, E. G., & Blaak, E. E. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00966-0 · Cited by 71
Altered Gut Microbiota: A Link Between Diet and the Metabolic Syndrome
Velasquez, M. T. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0163 · Cited by 66
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 64
Poljšak, B., Kovač, V., Špalj, S., & Milisav, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032959 · Cited by 56
Fedirko, V., Tran, H. Q., Gewirtz, A. T., Stepien, M., Trichopoulou, A., Aleksandrova, K., Olsen, A., Tjønneland, A., Overvad, K., Carbonnel, F., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0830-8 · Cited by 50
Berries as a Treatment for Obesity-Induced Inflammation: Evidence from Preclinical Models
Lail, H. L., Feresin, R. G., Hicks, D., Stone, B., Price, E., & Wanders, D. (2021) · Nutrients · doi:10.3390/nu13020334 · Cited by 46
Gastrointestinal Dysfunction and HIV Comorbidities
Sim, J. H., Mukerji, S. S., Russo, S. C., & Lo, J. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00537-8 · Cited by 40
Chronic oral infection: An emerging risk factor of cerebral small vessel disease
Aarabi, G., Thomalla, G., Heydecke, G., & Seedorf, U. (2018) · Oral Diseases · doi:10.1111/odi.12912 · Cited by 43
Bianchi, M. G., Allegri, M., Chiu, M., Costa, A. L., Blosi, M., Ortelli, S., Bussolati, O., & Bergamaschi, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00866 · Cited by 39
Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
Poljšak, B., Kovač, V., & Milisav, I. (2022) · Antioxidants · doi:10.3390/antiox11091637 · Cited by 42
Microbiota’s Role in Diet-Driven Alterations in Food Intake: Satiety, Energy Balance, and Reward
Rautmann, A. W., & Serre, C. B. D. L. (2021) · Nutrients · doi:10.3390/nu13093067 · Cited by 44
Gaber, M. K., Wilson, A. S., Millen, A. E., Hovey, K. M., LaMonte, M. J., Wactawski‐Wende, J., Ochs‐Balcom, H. M., & Cook, K. L. (2024) · Microbiome · doi:10.1186/s40168-024-01901-1 · Cited by 39
The Effect of Enteric-Derived Lipopolysaccharides on Obesity
Wang, K., Lai, W., Min, T., Wei, J., Bai, Y., Cao, H., Guo, J., & Su, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084305 · Cited by 38
The Role of Diet, Additives, and Antibiotics in Metabolic Endotoxemia and Chronic Diseases
Park, J., Park, H., Kim, Y., & Park, M. (2024) · Metabolites · doi:10.3390/metabo14120704 · Cited by 41
Leite, F. R. M., Peres, K. G., Do, L., Demarco, F. F., & Peres, M. A. (2017) · Journal of Periodontology · doi:10.1902/jop.2017.160607 · Cited by 34
Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH
Hegazy, M., Mogawer, S., Alnaggar, A. R., Ghoniem, O. A., & Samie, R. M. A. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s249949 · Cited by 34
Role of Periodontal Infection, Inflammation and Immunity in Atherosclerosis
Choi, H., Dey, A. K., Priyamvara, A., Aksentijevich, M., Bandyopadhyay, D., Dey, D. K., Dani, S. S., Guha, A., Nambiar, P. H., Nasir, K., et al. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100638 · Cited by 36
Antunes, B. M., Neto, J. C. R., Batatinha, H., Franchini, É., Teixeira, A. M., & Lira, F. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-70731-6 · Cited by 34
Metabolic Endotoxemia: From the Gut to Neurodegeneration
Chmielarz, M., Sobieszczańska, B., & Środa-Pomianek, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137006 · Cited by 37
Daulatzai, M. A. (2016) · Europe PMC (PubMed Central) · Cited by 31
Nozu, T., & Okumura, T. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm21002 · Cited by 31
Dopaminergic Pathways in Obesity-Associated Inflammation
Leite, F., & Ribeiro, L. V. P. T. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09863-0 · Cited by 34
Daulatzai, M. A. (2016) · Europe PMC (PubMed Central) · Cited by 60
RetractedAli, S., Malloci, M., Safiedeen, Z., Soleti, R., Vergori, L., Vidal‐Gómez, X., Besnard, C., Dubois, S. G., Lay, S. L., Boursier, J., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154727 · Cited by 27
Mokkala, K., Pussinen, P. J., Houttu, N., Koivuniemi, E., Vahlberg, T. J., & Laitinen, K. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0072 · Cited by 28
Self-citationOh, T. J., Ahn, C. H., & Cho, Y. M. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12444 · Cited by 28
Genetic Profile of Endotoxemia Reveals an Association With Thromboembolism and Stroke
Leskelä, J., Toppila, I., Härma, M., Palviainen, T., Salminen, A., Sandholm, N., Pietiäinen, M., Kopra, E., de Barros, J.-P. P., FinnGen, et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022482 · Cited by 25
Self-citationExercise and nutrition in type 1 diabetes: Insights from the FinnDiane cohort
Barlovič, D. P., Harjutsalo, V., & Groop, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064185 · Cited by 26
HIV and comorbidities – the importance of gut inflammation and the kynurenine pathway
MacCann, R., LANDAY, A. L., & Mallon, P. W. G. (2022) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000782 · Cited by 27
Wang, X., Liu, Y., Zhang, S., Ouyang, X., Wang, Y., Jiang, Y., & An, N. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15430 · Cited by 23
Sala, P., Torrinhas, R. S., Fonseca, D. C., Machado, N. M., Singer, J., Singer, P., Ravacci, G. R., Belarmino, G., Ferreira, B. D. A. M., Marques, M. Q., et al. (2020) · Nutrition · doi:10.1016/j.nut.2020.110885 · Cited by 21
Simonsen, J. R., Järvinen, A., Harjutsalo, V., Forsblom, C. M., Groop, P., & Lehto, M. J. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13138 · Cited by 17
Self-citationHuman Gut Microbiota in Cardiovascular Disease
Ronen, D., Rokach, Y., Abedat, S., Qadan, A., Daana, S., Amir, O., & Asleh, R. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230012 · Cited by 28
Cui, Y., Zhang, F., Xu, W., Li, Z., Zou, J., Gao, P., & Hu, J. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04013-9 · Cited by 17
Mikołajczyk, A., & Złotkowska, D. (2019) · Toxins · doi:10.3390/toxins11020091 · Cited by 18
Simonsen, J. R., Järvinen, A., Hietala, K., Harjutsalo, V., Forsblom, C. M., Groop, P., & Lehto, M. J. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-316202 · Cited by 17
Self-citationBishehsari, F., Drees, M., Adnan, D., Sharma, D., Green, S. J., Koshy, J., Giron, L. B., Goldman, A. R., Abdel‐Mohsen, M., Rasmussen, H. E., et al. (2023) · PROTEOMICS · doi:10.1002/pmic.202300023 · Cited by 14
Serum lipopolysaccharide neutralizing capacity in ischemic stroke
Leskelä, J., Pietiäinen, M., Safer, A., Lehto, M. J., Metso, J., Malle, E., Buggle, F., Becher, H., Sundvall, J., Grau, A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228806 · Cited by 13
Self-citationOh, T. J., Lee, H., & Cho, Y. M. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1879-0 · Cited by 14
Sex-Specific Metabolite Biomarkers of NAFLD in Youth: A Prospective Study in the EPOCH Cohort
Perng, W., Francis, E. C., Smith, H., Carey, J., Wang, D., Kechris, K. J., & Dabelea, D. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa467 · Cited by 13
Ogilvie, A. R., Onishi, J. C., Schlussel, Y., Kumar, A., V, Häggblom, M. M., Kerkhof, L. J., & Shapses, S. A. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.06.001 · Cited by 14
Rodríguez-Vera, D., Vergara‐Castañeda, A., Lazcano-Orozco, D. K., Ramírez-Vélez, G., Vivar-Sierra, A., Araiza-Macías, M. J., Contreras, J. P. H., Naranjo-Navarro, C. R., Salazar, J. R., Loza-Mejía, M. A., et al. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0022 · Cited by 14
Oral health: A modifiable risk factor for cardiovascular diseases or a confounded association?
Pussinen, P. J., & Könönen, E. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316636506 · Cited by 11
Self-citationMehmood, K., Moin, A., Hussain, T., Rizvi, S. M. D., Gowda, D., Shakil, S., & Kamal, M. (2021) · Folia Microbiologica · doi:10.1007/s12223-021-00926-5 · Cited by 11
Rehues, P., Rodríguez, M. M., Alvarez-Borillo, J., Jiménez, M. P. C., Melià, A., Sempere, M., Balsells, C., Castillejo, G., Guardiola, M., Castro, A., et al. (2021) · Biomolecules · doi:10.3390/biom12010047 · Cited by 10
Perng, W., Friedman, J. E., Janssen, R. C., Glueck, D. H., & Dabelea, D. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac149 · Cited by 10
Infection and food combine to cause atherosclerotic coronary heart disease – Review and hypothesis
Lawson, J. S., & Glenn, W. K. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100807 · Cited by 11
Gender Differences in the Gut Microbiome and How These Affect Cardiovascular Diseases
Rosel, A. C., Wassenaar, T. M., & Ussery, D. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-71135-5_7 · Cited by 10
Gut microbiome metabolites as key actors in atherosclerosis co-depression disease
Liao, X.-X., Wu, X., Zhou, Y.-L., Li, J., Wen, Y.-L., & Zhou, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.988643 · Cited by 10
Viewpoint: Is lipopolysaccharide a hormone or a vitamin?
Jiang, W., & Banks, W. A. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.018 · Cited by 9
Influence of Energy Balance and Glycemic Index on Metabolic Endotoxemia in Healthy Men
Breusing, N., Lagerpusch, M., Engstler, A. J., Bergheim, I., Mueller, M. J., & Bosy‐Westphal, A. (2017) · Journal of the American College of Nutrition · doi:10.1080/07315724.2016.1156036 · Cited by 9
Δάσκου, Μ., Sharma, M. B., Mu, W., Heymans, R., Ritou, E., Rezek, V. K., Hamid, P., Kossyvakis, A., Roy, S. S., Grijalva, V. R., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154888 · Cited by 9
Cardiovascular Involvement in Sepsis
Turillazzi, E., Fineschi, V., Palmière, C., & Sergi, C. M. (2016) · Mediators of Inflammation · doi:10.1155/2016/8584793 · Cited by 9
Kwon, H.-S., Kim, S.-J., Shin, K. J., Kim, S. H., Yun, J., Bae, J., Tak, H.-J., Lee, N., & Kim, H.-J. (2024) · Nutrients · doi:10.3390/nu16131993 · Cited by 8
Metabolic endotoxemia: possible causes and consequences
Beloglazov, V. A., Yatskov, I. A., Кумельский, Е. Д., & Polovinkina, V. V. (2021) · Obesity and metabolism · doi:10.14341/omet12750 · Cited by 8
Association between severity of dental caries and the risk of stroke
Ono, Y., Chou, Y., Chien, W., & Sun, C. (2023) · Oral Diseases · doi:10.1111/odi.14756 · Cited by 8
Gut-Heart Axis: Microbiome Involvement in Restrictive Cardiomyopathies
Alvarado, S. J., López-Tenorio, I. I., Santos, J. B.-D. L., Bello-Vega, D. C., Roldán, F., Amedei, A., Berrios-Bárcenas, E. A., & Aguirre‐García, M. M. (2025) · Biomedicines · doi:10.3390/biomedicines13010144 · Cited by 9
Cornò, M. D., Aureli, A., Varano, B., & Conti, L. (2026) · Biomolecules · doi:10.3390/biom16020226 · Cited by 8
Climate Change, Urbanisation, and Their Impact on Increased Occurrence of Cardiometabolic Syndrome
Choudhury, S. P., Arora, A., Jain, N., & Dey, S. K. (2022) · doi:10.1002/9781119807216.ch2 · Cited by 7
Trandafir, L. M., Cojocaru, E., Moscalu, M., Leon, M. M., Miron, I. C., Maștaleru, A., Teslariu, O., Datcu, M., Fotea, S., & Frăsinariu, O. E. (2021) · Diagnostics · doi:10.3390/diagnostics11040735 · Cited by 6
Impact of Early Nutrition on Intestinal Microbiome: Effects on Immunity and Long-Term Health
Laitinen, K., Mokkala, K., & Kalliomäki, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100168-4.00008-2 · Cited by 5
Federici, M. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01315-8 · Cited by 6
Mikołajczyk, M., Złotkowska, D., & Mikołajczyk, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211868 · Cited by 5
Metadata
- Authors
- Kallio, K. A. E., Hätönen, K. A., Lehto, M., Salomaa, V., Männistö, S., & Pussinen, P. J.
- Affiliations
- University of Helsinki (FI)
- Finnish Institute for Health and Welfare (FI)
- Helsinki University Hospital (FI)
- Corresponding author
- Kallio, K. A. Elisa
- Venue
- Acta Diabetologica
- Published
- 2014-10-19
- Volume
- 52
- Issue
- 2
- Pages
- 395-404
- ISSN
- 0940-5429 (ISSN-L)
- 1432-5233
- OpenAlex
- W2016971083
- Cited by
- 125
- References
- 38
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 11 · 2023: 7 · 2022: 13 · 2021: 17 · 2020: 18 · 2019: 7 · 2018: 12 · 2017: 12 · 2016: 13 · 2015: 10
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Diabetologica (publishedVersion)
- PubMed (publishedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- Aarne Koskelon Säätiö
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- endotoxemia, lipopolysaccharide, macronutrient intake, carbohydrate intake, energy intake, obesity, metabolic syndrome, diabetes mellitus, coronary artery disease, cardiometabolic disease, gut microbiota, bacterial infection, inflammation
- MeSH terms
- Adult, Aged, Energy Intake, Coronary Disease, Endotoxins, Female, Follow-Up Studies, Humans, Lipopolysaccharides, Male, Middle Aged, Cohort Studies, Nutrition Assessment, Endotoxemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review